Robert Lisicki
Chief Executive Officer chez ZURA BIO LIMITED
Fortune : - $ au 31/03/2024
Provenance du réseau au premier degré de Robert Lisicki
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 20 | |
| Public Company | Biotechnology | 18 | |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
| Unknown | 7 | ||
Adiso Therapeutics, Inc.
 Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022.
3
| Holding Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robert Lisicki via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Comptroller/Controller/Auditor Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
DJO Global, Inc.
 DJO Global, Inc. Medical SpecialtiesHealth Technology DJO Global, Inc. engages in the development and distribution medical devices for musculoskeletal health, joint reconstruction, vascular health, and pain management. Its product include knee ligament bracing, custom bracing, post-op knee bracing, hip implants, shoulder implants, shoulder bracing, spine bracing, cervical collars, walking braces, and ankle bracing. The company was founded by Mark Nordquist and Ken Reed in 1978 and is headquartered in Lewisville, TX. | Medical Specialties | Director/Board Member | |
| MARKER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Director of Finance/CFO | |
| MONARCH STAFFING, INC. | Services to the Health Industry | Director/Board Member Director of Finance/CFO | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
DJO Finance LLC
 DJO Finance LLC Medical SpecialtiesHealth Technology DJO Finance LLC develops, manufactures and distributes medical devices with a products used for rehabilitation, pain management and physical therapy. The company was founded in 2006 and is headquartered in Vista, CA. | Medical Specialties | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
2020, Inc.
 2020, Inc. Medical/Nursing ServicesHealth Services 2020, Inc. offers eye care services. It also offers delivers on-site eye care and eye exams to businesses and their employees via a mobile eye clinic. The company was founded by Howard Bornstein in 2013 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member | |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Biotechnology | Director/Board Member | |
Cancer Targeting Systems, Inc.
 Cancer Targeting Systems, Inc. BiotechnologyHealth Technology Cancer Targeting Systems, Inc. offers cancer care. The firm focuses on delivering cancer theranostic products combining imaging with therapy. The company was founded by Martin Pomper and Will West and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Human Resources Officer Director of Finance/CFO | |
| Iowa State University | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Masters Business Admin | |
Morningside Group Ltd.
 Morningside Group Ltd. Investment ManagersFinance Morningside Group (Morningside Group) is a venture capital and private equity firm founded in 1986 by Lok Chung Chan and Chi Chung Chan. The firm is headquartered in Hong Kong. | Investment Managers | Consultant / Advisor | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal Chairman | |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
SMART Reading /Oregon/
 SMART Reading /Oregon/ Miscellaneous Commercial ServicesCommercial Services SMART Reading offers literacy support to children. It helps kids become confident readers by providing individual volunteer attention and new, take-home books. The company was founded in 1992 and is headquartered in Portland, OR. | Miscellaneous Commercial Services | Director/Board Member | |
Graham Packaging Holdings Co. (Pennsylvania)
 Graham Packaging Holdings Co. (Pennsylvania) Chemicals: SpecialtyProcess Industries Graham Packaging Holdings Co. manufactures and sells plastic containers. The firm supplies plastic containers for hot-fill juice and juice drinks, sports drinks, drinkable yogurt and smoothies, nutritional supplements, and beverages. The company was founded in 1970 and is headquartered in Lancaster, PA. | Chemicals: Specialty | Director/Board Member | |
| Graduate School of Business | College/University | Masters Business Admin | |
Eden Woods Investments LLC
 Eden Woods Investments LLC Financial ConglomeratesFinance Eden Woods Investments LLC provides investment services. The company was founded on May 5, 2011 and is headquartered in Rancho Santa Fe, CA. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
| LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | General Counsel Director/Board Member Chief Operating Officer Chief Executive Officer Director/Board Member | |
Espero Pharmaceuticals, Inc.
 Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Espero Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing therapeutics for unmet needs in thrombosis and cardiac rhythm control. Espero Pharmaceuticals is based in Jacksonville, FL and has subsidiaries in the United States. The private company's portfolio includes tecarfarin, which is used for patients requiring anticoagulation, and a novel candidate for treating arrhythmias. The company was founded by Jeffrey S. Cole and Quang X. Pham. | Medical Distributors | Chief Executive Officer Founder | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| METACRINE, INC. | Biotechnology | Chief Executive Officer Human Resources Officer | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The private company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The private company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 43 |
| Irlande | 2 |
| Hong Kong | 2 |
| Royaume-Uni | 2 |
| France | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 5 |
| Process Industries | 3 |
Opérationnelle
| Director/Board Member | 158 |
| Corporate Officer/Principal | 109 |
| Independent Dir/Board Member | 51 |
| Chief Tech/Sci/R&D Officer | 48 |
| Director of Finance/CFO | 44 |
Relations les plus connectées
| Insiders | |
|---|---|
| Scott Gottlieb | 26 |
| Amit Munshi | 26 |
| Matthew Szot | 23 |
| Jason Robert Dinges | 22 |
| Jennifer Jarrett | 18 |
| John Murphy | 17 |
| Christopher Cabell | 16 |
| Preston Klassen | 15 |
| Douglas Losordo | 14 |
| Neil Graham | 14 |
| Laurie Stelzer | 13 |
| Vincent Aurentz | 13 |
| Glynn Wilson | 13 |
| Manmeet Singh Soni | 13 |
| Randall E. Woods | 13 |
- Bourse
- Insiders
- Robert Lisicki
- Connexions Sociétés
